PMID: 3756820Nov 1, 1986Paper

Ovarian epithelial tumors of borderline malignancy. A clinical and pathologic study of 109 cases

Cancer
D G BostwickR L Kempson

Abstract

One hundred nine cases of ovarian tumors of low malignant potential (borderline tumors) diagnosed at Stanford University Medical Center from 1958 to 1982 were reviewed. The patients ranged in age from 10 to 79 years (mean, 40.5 years). The histologic types and corresponding stages of these neoplasms were 73 serous (Stage IA: 35 patients; Stage IB+C: 16 patients; stage II: 8 patients; Stage III: 14 patients), 30 mucinous (Stage IA: 27 patients; Stage IB+C: 3 patients), and 6 mixed seromucinous (all Stage IA). Borderline endometrioid, clear cell, and Brenner tumors were excluded. Follow-up information from 3 to 27 years from the time of initial diagnosis (mean, 7.6 years; median, 7.1 years) revealed that 89 patients are alive without further evidence of neoplasm, and three patients died of unrelated disease without recurrent tumor. Seventeen patients have developed persistent or recurrent neoplasms in the contralateral ovary (six patients) and/or elsewhere within the peritoneal cavity (15 patients) at 5 to 226 months (mean, 61 months) after the initial excision. All of the second neoplasms were borderline serous or seromucinous tumors histologically identical to the original tumor; none of the borderline mucinous tumors recurred....Continue Reading

References

Nov 1, 1977·Histopathology·A A BlancoF A Langley
Feb 1, 1979·The Australian & New Zealand Journal of Obstetrics & Gynaecology·P Russell, H Merkur
Dec 1, 1978·The American Journal of Surgical Pathology·A L KatzensteinM S Kao
Mar 1, 1969·American Journal of Obstetrics and Gynecology·E W Munnell
Mar 1, 1984·Gynecologic Oncology·D GuthrieP R Philips
Jan 1, 1983·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·T J Colgan, H J Norris
Mar 1, 1982·The American Journal of Surgical Pathology·K R Zinsser, J E Wheeler
Dec 1, 1982·Gynecologic Oncology·M J WebbD G Decker
Mar 15, 1982·American Journal of Obstetrics and Gynecology·G C StuartR J Anderson
Jul 1, 1981·Histopathology·J P BaakE Brekelmans
Mar 15, 1980·American Journal of Obstetrics and Gynecology·R L EhrmannR C Knapp
May 1, 1954·American Journal of Obstetrics and Gynecology·J D WOODRUFF, E R NOVAK
Nov 1, 1949·American Journal of Obstetrics and Gynecology·E W MUNNELL, H C TAYLOR

❮ Previous
Next ❯

Citations

Feb 1, 1997·Journal of Surgical Oncology·K TamakoshiY Tomoda
Jun 22, 1999·Cancer·L R DuskaN Nikrui
Sep 5, 2002·Cancer·David M Gershenson
Sep 5, 2002·Cancer·Robert E BristowFredrick J Montz
Jul 14, 2005·Archives of Gynecology and Obstetrics·Tsuyoshi OhtaHirohisa Kurachi
Jul 16, 2010·Archives of Gynecology and Obstetrics·Muzaffer SanciYusuf Yildirim
May 22, 2007·Surgical Endoscopy·E DaraïG Dubernard
Nov 2, 2004·Familial Cancer·Murray Joseph Casey, Chhanda Bewtra
May 18, 2005·Gynecologic Oncology·Nurettin BoranM Faruk Kose
Mar 22, 2000·Obstetrics and Gynecology·R T MorrisJ T Wharton
Mar 12, 2005·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·William R Hart
Mar 10, 2001·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·C. W. BurgerP. Kenemans
Oct 18, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R FauvetE Daraï
Jan 1, 1997·The American Journal of Surgical Pathology·B M WenigC S Heffess
Sep 10, 2002·The American Journal of Surgical Pathology·Michael T DeaversElvio G Silva
Dec 24, 2002·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·C Blake GilksDianne M Miller
Jan 1, 1995·Obstetrical & Gynecological Survey·U ElchalalJ G Schenker
Oct 1, 1996·Obstetrical & Gynecological Survey·J Menczer
Oct 26, 2006·The American Journal of Surgical Pathology·Elvio G SilvaMichael Deavers
Jun 1, 2007·Journal of Computer Assisted Tomography·Tadao HiromuraKazuo Tomita
Jun 24, 2011·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Philippe MoriceUNKNOWN Fertility Task Force of the European Society of Gynecologic Oncology
Sep 22, 2007·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·Robert E EmersonLiang Cheng
May 1, 1991·The Australian & New Zealand Journal of Obstetrics & Gynaecology·A AyhanF Bilgin
Feb 1, 1997·The Australian & New Zealand Journal of Obstetrics & Gynaecology·M ButtiniA Crandon
Mar 7, 2006·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·E-J LeeJ J Kavanagh
Mar 21, 2007·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·D PectasidesM A Dimopoulos
Jun 17, 1997·Annals of the New York Academy of Sciences·S K Fotiou
Jun 17, 1997·Annals of the New York Academy of Sciences·A J Tserkezoglou

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.